Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 and Phase 2, Multi-Center, Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Evidence of Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

NCT06609005 is registered in ClinicalTrials.gov with Shenzhen Ionova Life Sciences Co., Ltd. as lead sponsor.

NCT NCT06609005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06609005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 and Phase 2, Multi-Center, Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Evidence of Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Lead sponsor
Shenzhen Ionova Life Sciences Co., Ltd.
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 23, 2025
Completion date
January 17, 2028
Enrollment
84 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

advanced metastatic castration resistant prostate cancer